Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations
about
Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthroughAdditional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthroughOmeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.pH, healing rate, and symptom relief in patients with GERD.Diagnosis and treatment of gastroesophageal reflux disease.The Indications, Applications, and Risks of Proton Pump InhibitorsClinical pharmacology and therapeutics.Comparative role of omeprazole in the treatment of gastroesophageal reflux disease.Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis.Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.Medical management of esophageal reflux.Prospective Study of Gastroesophageal Reflux, Use of Proton Pump Inhibitors and H2-Receptor Antagonists, and Risk of Hearing Loss.Efficacy of proton pump inhibitors and H2 blocker in the treatment of symptomatic gastroesophageal reflux disease in infants.Trends in the management of gastro-oesophageal reflux diseaseBiochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.
P2860
Q24240662-3B6C0B16-9090-46C8-85D3-B9373F8A073AQ24246606-C5F14340-5FD1-4C53-B9E1-0AE06ED1193AQ33624127-5A28A3DB-69DE-40F2-9F6A-CFFF26C73621Q33898648-2949E39D-B674-4FB2-849B-ED46AD2FE68BQ34047646-5A8A8DC6-D38D-4D6D-AC29-8A1FD1AB0F90Q36091187-04CFA035-95EA-4E49-8447-844C54BDCC21Q36682367-376D0D6D-8B7F-4F37-9AF0-DD18156526C8Q36803997-656016BB-9998-4419-ACC4-F128FE3FB7F9Q37248763-AD698648-035C-42DD-98FA-1E77271327F9Q39252347-158BC4DB-902A-4B74-BEB6-7615861BE048Q39444480-DA186513-E744-4795-BDD3-49162C2B5A72Q40383590-9A73C11C-113D-409D-8564-F45FD03DA720Q40609376-7BE2F441-9341-4DE3-92CD-DF580CE2A177Q42063228-CCA22149-F782-4149-BC3D-AA654B1B5A47Q42124636-D6388010-8B6F-41D5-A971-4B49554F6B75Q47919662-E3C525FA-29CB-485F-A8C7-681F808CAD15Q51581340-4E5DD9A8-A4B0-44AA-A884-963B9A4CB171
P2860
Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations
description
1990 nî lūn-bûn
@nan
1990 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Comparison of omeprazole and c ...... , and histological evaluations
@ast
Comparison of omeprazole and c ...... , and histological evaluations
@en
Comparison of omeprazole and c ...... , and histological evaluations
@nl
type
label
Comparison of omeprazole and c ...... , and histological evaluations
@ast
Comparison of omeprazole and c ...... , and histological evaluations
@en
Comparison of omeprazole and c ...... , and histological evaluations
@nl
prefLabel
Comparison of omeprazole and c ...... , and histological evaluations
@ast
Comparison of omeprazole and c ...... , and histological evaluations
@en
Comparison of omeprazole and c ...... , and histological evaluations
@nl
P2093
P2860
P356
P1433
P1476
Comparison of omeprazole and c ...... , and histological evaluations
@en
P2093
Keeling PW
Mountford RA
O'Morain C
Temperley JM
Thompson DG
Wilkinson SP
P2860
P304
P356
10.1136/GUT.31.9.968
P407
P577
1990-09-01T00:00:00Z